Investing Profile

Curt LaBelle

InvestorVC
Venture Partner at Adjuvant Capital
adjuvantcapital.com/team/New York, New York
Photo of Curt LaBelle, Venture Partner at Adjuvant Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Adjuvant Capital Venture Partner
$100K - $5.0M
$1.5M
6
$300M
CompanyStageDateRound SizeTotal Raised
Vedanta Biosciences
Series EApr 2023$110M
$110M
Co-investors: Martin Heidecker (AMR Action Fund)
Ophirex
Series BJan 2023$37M
$37M
Epion Therapeutics
Series ASep 2022$32M
$32M
Alydia Health
Series CJul 2020$14M
Series BAug 2018$10M
$24M
Co-investors: Charles Petty, Kimberly Vogel
Iantech
Series CJul 2017$5M
$5M
Co-investors: Charles Petty